Skip to main content
OpenTrials
Completed

NCT Number: NCT00440024

The Effect Of A Controlled Daily Skin Care Regimen On Retinoic Acid Tolerance

Sun-damaged skin, caused by chronic exposure to ultraviolet (UV) light, is characterized by features such as wrinkling, uneven skin color, roughness and brown spots. An effective treatment for sun-damage that is commonly prescribed is topical retinoic acid (RA). However, the major drawback of topical RA use has been frequently observed irritation characterized by redness, dry skin and severe itching. In this study, we examine whether a daily skin care regimen comprised of an ultra mild cleanser and an effective moisturizer can help improve tolerance to RA treatment.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Michigan Department of Dermatology

Ann Arbor, Michigan, 48109, United States

About this study

Sun-damaged skin, caused by chronic exposure to ultraviolet (UV) light, is characterized by features such as wrinkling, uneven skin color, roughness and brown spots. An effective treatment for sun-damage that is commonly prescribed is topical retinoic acid. However, the major drawback of topical retinoic acid use has been frequently observed irritation characterized by redness, dry skin and severe itching. In this study, we examine whether a daily skin care regimen comprised of an ultra mild cleanser and an effective moisturizer can help improve tolerance to retinoid treatment.

Subjects for whom retinoid treatment is indicated for sun-damage will be recruited into the study. The retinoid intolerance will be established via prior history (detailed questionnaire) and a 2-week retinoid treatment (Tazarotene 0.1% cream) phase followed by clinical evaluation and determination of retinoid intolerance.

Subjects that exhibit retinoid intolerance will continue with the study. Approximately 30 subjects will be put on a controlled daily skin care regimen during the remainder of the study period while the rest of the subjects will continue their normal skin care habits. The controlled skin care regimen will consist of facial cleansing with a Dove ultra mild emollient cleanser and application of Dove facial moisturizer, used as normal. During this period, subjects will be evaluated to determine reduction of retinoid intolerance symptoms.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Caucasians between the ages of 40 and 90 with moderate to severe sun-damage on the face who are generally healthy may participate.
  • You must demonstrate a previous history of retinoid intolerance (established through prior history and the 2-week retinoid treatment phase of this study).
  • Women of childbearing potential must agree to use an accepted form of birth control for the entire duration of the study.
  • You must live within a reasonable driving distance of Ann Arbor, Michigan, and/or be able to attend all of the scheduled appointments during the study.

Exclusion criteria

  • You may not have used any topical or systemic retinoids in the past 6 months.
  • Women who are pregnant or nursing may not participate.
  • If you have a history of non-melanoma skin cancer on the face in the past 5 years, you may not participate.
  • If you have any history of malignant melanoma you may not participate.
  • If you have any other skin condition or facial hair that will interfere with the study evaluations, you may not participate.
  • If you have a known sensitivity to any of the ingredients in the study cream or Dove products, you may not participate.
  • If you are currently on special daily skin care regimens that include cleansing with Dove, Olay, Aveeno or Cetaphil liquid facial cleansers and using facial moisturizers more than twice a day you may not participate.

Treatment and study plan

Tazorac

Drug

Tazarotene 0.1% cream applied to the face once daily before bed

Other names: Tazarotene

Dove Mild Cleanser

Drug

Ultra mild cleanser: Dove Non-foaming cleansing lotion

Other names: Dove Non-foaming Cleanser

Dove Facial Moisturizer

Drug

Moisturizing cream - Dove facial moisturizer with SPF 15

Primary outcomes

  1. Retinoid irritation symptoms

    Time frame: Weeks 6, 8, 12, 16, 20 and 24

  2. Improvement of sun-damage (wrinkling, uneven skin color, roughness and brown spots).

    Time frame: At the end of the study (week 24)

Secondary outcomes

  1. Treatment effects, such as erythema, peeling, itching, and burning/stinging will be evaluated at each study visit.

    Time frame: Weeks 6, 8, 12, 16, 20 and 24

Sponsors and collaborators

Lead sponsor

University of Michigan

Other

Collaborators

  • Unilever R&D

Registry information

Official study title

A Single-Blind Study to Assess Benefits of a Controlled Daily Skin Care Regimen on Retinoid Intolerant Patients (Derm 570)

Important dates

Study start
2007
Primary completion
2009
Study completion
2009
First posted
Feb 26, 2007
Registry last updated
Mar 13, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.